Malignant insulinoma chemotherapy resistant, pancreatic neuroendocrine tumor of uncertain prognosis

Gonzalo Miranda1
1Servicio de Endocrinología del Hospital Nacional Dos de Mayo, Peru

Tài liệu tham khảo

Service, 1991, Functioning insulinoma–incidence, recurrence, and long-term survival of patients: a 60-year study, Mayo Clin Proc, 66, 711, 10.1016/S0025-6196(12)62083-7 Whipple, 1935, Adenoma of islet cells with hyperinsulinism: a review, Ann Surg, 101, 1299, 10.1097/00000658-193506000-00001 Shin, 2010, Insulinoma: pathophysiology, localization and management, Future Oncol, 6, 229, 10.2217/fon.09.165 Cryer, 2008, Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline, J Clin Endocrinol Metabol, 94, 709, 10.1210/jc.2008-1410 Okabayashi, 2013, Diagnosis and management of insulinoma, World J Gastroenterol, 19, 829, 10.3748/wjg.v19.i6.829 Dr. Ramón Salazar, Dr. José Ángel Díaz, Dra. Mercedes Robledo. Tumores neuroendocrinos. Mecanismos moleculares y aplicaciones clínicas. Curso de la escuela europea de oncología. Sesión II, páginas: 28 al 32. Cryer, 2009, Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline, Clin Endocrinol Metab, 94, 709, 10.1210/jc.2008-1410 Strosberg, 2012, Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications, Ann Surg, 256, 321, 10.1097/SLA.0b013e31824e6108 Strosberg, 2011, Prognostic validity of a novel American Joint committee on cancer staging classification for pancreatic neuroendocrine tumors, J Clin Oncol, 29, 3044, 10.1200/JCO.2011.35.1817 Cho, 2016, Prognostic validity of the American Joint committee on cancer and the European neuroendocrine tumors staging classifications for pancreatic neuroendocrine tumors: a retrospective nationwide multicenter study in South Korea, Pancreas, 45, 941, 10.1097/MPA.0000000000000586 Placzkowski, 2009, Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007, J Clin Endocrinol Metabol, 94, 1069, 10.1210/jc.2008-2031 Hirshberg, 2005, Malignant insulinoma: spectrum of unusual clinical features, Cancer, 104, 264, 10.1002/cncr.21179 Carty, 1992, Prospective study of aggressive resection of metastatic pancreatic endocrine tumors, Surgery, 112, 1024 Modlin, 1993, Management of unresectable malignant endocrine tumors of the pancreas, Surg Gynecol Obstet, 176, 507 McEntee, 1990, Cytoreductive hepatic surgery for neuroendocrine tumors, Surgery, 108, 1091